Prepare for your visit
Molly Davis
Gerontology (Nurse Practitioner) · Denver, CO · NPI 1467114322
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,452.58
in general payments reported to CMS, 2019-2025 · $1,556 in 2025
The $1,556 reported for 2025 was more than what 91% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Who reported paying
General payments only, top 6 by amount.
- Merck Sharp & Dohme LLC $266.79
- Janssen Biotech, INC. $243.94
- Daiichi Sankyo INC. $198.80
- Pfizer INC. $162.87
- Gilead Sciences, INC. $160.46
- Astrazeneca Pharmaceuticals LP $157.59
Drugs and devices associated with these payments
Keytruda Darzalex Lynparza Trodelvy Tecvayli Talvey Enhertu Tukysa Orserdu Ayvakit Braftovi Mektovi
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Molly Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11265815/molly-davis